Back to search
FDAFDA · Food and drugs·Recall number D-1448-2016

Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09

Published August 3, 2016 · Recall initiated: July 11, 2016

Summary

FDA records drug Class II recall D-1448-2016, published August 3, 2016 and initiated July 11, 2016. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 8,062 units; Lot: Lot #: 3803J141, Exp. 7/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if DEXTROAMPHETAMINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXTROAMPHETAMINE SULFATE
Manufacturer
Actavis Inc
Distributor
Nationwide
UPC
0345963305091
Lot
Lot #: 3803J141, Exp. 7/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09 recalled?

Yes. FDA published recall D-1448-2016 on August 3, 2016. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXTROAMPHETAMINE SULFATE. UPC: 0345963305091.